Results 11 to 20 of about 67,209 (213)

Meningococcal disease serogroup C

open access: yesRisk Management and Healthcare Policy, 2012
Despite current advances in antibiotic therapy and vaccines, meningococcal disease serogroup C (MDC) remains a serious threat to global health, particularly in countries in North and Latin America, Europe, and Asia. MDC is a leading cause of morbidity, mortality, and neurological sequelae and it is a heavy economic burden.
Dickinson,Félix O   +2 more
openaire   +5 more sources

Evolution of serogroup 6

open access: yes, 2017
This is a high resolution figure of the analysis of serogroup 6.
Rafal Mostowy (3708628)
openaire   +2 more sources

Bacterial outer membrane vesicles and vaccine applications [PDF]

open access: yes, 2014
Vaccines based on outer membrane vesicles (OMV) were developed more than 20 years ago against Neisseria meningitidis serogroup B. These nano-sized structures exhibit remarkable potential for immunomodulation of immune responses and delivery of “self ...
Jose Luis Perez   +30 more
core   +4 more sources

New serogroup of Legionella pneumophila, serogroup 8 [PDF]

open access: yesJournal of Clinical Microbiology, 1983
A strain of Legionella pneumophila (designated Concord 3) was isolated from a postmortem lung specimen of a patient with pneumonia. Direct fluorescent-antibody and immunoelectrophoresis tests, using absorbed and unabsorbed reagents prepared to this and other strains of legionellae, indicated that the Concord 3 strain represents a new serogroup of L ...
M L, Bissett, J O, Lee, D S, Lindquist
openaire   +2 more sources

Serogroup F, a new capsule serogroup of Pasteurella multocida [PDF]

open access: yesJournal of Clinical Microbiology, 1987
Four capsule serogroups (A, B, D, and E) have been described by using passive hemagglutination tests. Serogroups A and D predominant in pasteurelloses of avian species. A new capsule serogroup of Pasteurella multocida has been isolated from turkeys in Arkansas, California, Indiana, Iowa, Missouri, New Jersey, and Virginia.
R B, Rimler, K R, Rhoades
openaire   +2 more sources

Meningococcal disease in children in Merseyside, England : a 31 year descriptive study [PDF]

open access: yes, 2011
Meningococcal disease (MCD) is the leading infectious cause of death in early childhood in the United Kingdom, making it a public health priority. MCD most commonly presents as meningococcal meningitis (MM), septicaemia (MS), or as a combination of the ...
Hart, C. Anthony   +46 more
core   +6 more sources

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology [PDF]

open access: yesBMC Infectious Diseases, 2010
Invasive meningococcal disease (IMD), is a widely distributed, complex human disease affecting all age categories. The causative agent, Neisseria meningitidis, is spread through aerosol respiratory droplets. 13 different serogroups have been identified, each with varying epidemiological features including prevalence, virulence, immunogenicity ...
Racloz, V. N., Luiz, S. J.
openaire   +7 more sources

Serogrouping of Rhodococcus equi [PDF]

open access: yesMicrobiology and Immunology, 1983
AbstractThe serological relationships among 27 isolates of Rhodococcus equi selected from a total of 1,195 isolates were investigated by cross‐agglutination and absorption tests. The presence of capsular material was demonstrated in all the 27 isolates by electron microscopic observation.
M, Nakazawa   +3 more
openaire   +2 more sources

Identification of streptococci: serogrouping by immunofluorescence [PDF]

open access: yesJournal of Clinical Microbiology, 1975
This paper deals with the fluorescent antibody (FA) method for identifying six commonly occuring and two rare groups of streptococci by using commercially prepared (Difco) conjugates. We have shown that group-specific FA produced frequent cross-reactions with heterologous groups of organisms.
B K, Watson, L J, Kunz, R C, Moellering
openaire   +2 more sources

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013. [PDF]

open access: yes, 2015
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad.
Greenwood, Brian M   +35 more
core   +1 more source

Home - About - Disclaimer - Privacy